Strongbridge Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for STRONGBRIDGE, and when can generic versions of STRONGBRIDGE drugs launch?
STRONGBRIDGE has one approved drug.
There are seven US patents protecting STRONGBRIDGE drugs.
There are twenty-eight patent family members on STRONGBRIDGE drugs in twenty countries.
Summary for Strongbridge
| International Patents: | 28 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Strongbridge
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 11,278,547 | See Plans and Pricing | See Plans and Pricing | ||||
| Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 10,098,877 | See Plans and Pricing | See Plans and Pricing | ||||
| Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 10,517,868 | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Strongbridge Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 2007008331 | See Plans and Pricing |
| Japan | 2008526830 | See Plans and Pricing |
| Norway | 20074117 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
